The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...

An FDA database analysis shows that reported adverse skin events after GLP-1 receptor agonist use are rare but can include rash and pruritus, highlighting a need for further research, according to a ...

Jessa Milender injected herself with her mum's weight loss medication after feeling a pain in her stomach - and was rushed to ...

US regulator issues complete response letter on self-administered Saphnelo as Astra works to resubmit application.

There’s a new therapy being tested at Rochester Regional that will make patients with chronic heart failure sweat.

Natura Resources and NGL Energy have announced a strategic agreement to pair advanced nuclear ...

Researchers will highlight new injection systems, wearable devices and testing services supporting high-viscosity biologics, ...

The documentary seeks to shed new light on the trial of the neonatal nurse who was found guilty of murdering babies ...

OYE Therapeutics has been authorized to initiate clinical development of its OYE-101 caffeine injection after the U.S. FDA cleared its Investigational New Drug applications. OYE-101 is a novel ...

A health care tool for an overlooked public health problemFear of needles is one of health care’s most common, and most ...

Freedom Functional Medicine is ringing in the New Year by offering the latest noninvasive device to optimize mental health.

Feb 3 () - AstraZeneca said on Tuesday the U. health regulator has rejected ​its application for a self-injectable version ...